TAG:
dso
“September 24, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
Many different professions lost good people as a result of the terrorist attack on the World Trade Center in New York City on September 11. However, the clinical laboratory industry and the pathology profession seems to have emerged unscathed. Following many conversations with laboratorians throughou…
Public Labs Enjoy Boom Times As Revenues & Profits Climb
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
TAKEN COLLECTIVELY, second quarter earnings reports by public lab and pathology companies send a strong message: the lab industry is in the midst of a revenue and profit boom. It’s been more than a decade since every public lab and pathology company reported strong growth in both revenues and oper…
Unilab Files Registration For IPO of $115 Million
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: During the 1990s, Unilab used the twin strategies of lab acquisitions and aggressive sales and marketing to fuel rapid growth in specimen volumes and net revenues. However, California’s ultra-competitive managed care market and severe financial problems during the latter ha…
Market Changes Lead LabCorp To Follow New Strategic Direction
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
CEO SUMMARY: When formed in 1995, Laboratory Corporation of America faced a financially-hostile marketplace for lab testing services. However, strategic planning retreats in 1997 and 1999 were pivotal in redirecting this billion-dollar lab behemoth toward financial stability. During 2000,…
IPO Is Major Strategy For American Med Labs
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial publi…
Dynacare Sets Sights On Raising $89 Million
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care cont…
Merger Creates “New” Pathology Competitor
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: Pathology business consolidation and regionalization continues. Pathology Consultants of America, Inc. (PCA) and PathSOURCE, Inc. announced their intention to merge last month. The combined company will be called Inform DX, Inc. and will compete nationally for anatomic pathol…
“September 20, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
Here’s an interesting company to keep an eye on. Abaton.com, based in Minneapolis, is one of the early entrants in the race to offer web-based clinical network solutions at the point of care. Centrex Clinical Laboratories, Inc. of Utica, New York is purchasing Abat…
“April 26, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
Think turnover among laboratory executives and administrators is high? Get a load of this! Among CEOs at the nation’s 4,838 general, non-federal acute-care hospitals, the turnover rate was 16.9% during 1998. This was up from 12.1% in 1997. It means that one of every six hospitals got a new CEO last…
Improved 3rd Quarter Performance Posted By National Laboratories
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
Third quarter financial performance at all three national laboratories improved over the same period of 1997. It is an important sign that the three companies are stabilizing their finances. All three national laboratories continue to emphasize cost-cutting as a major corporate priority. That is to …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized